MedTrace Logo

Study of Proteins in Head and Neck Cancer Cells

NCT00896948 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2017-03-14

No results posted yet for this study

Summary

RATIONALE: Studying proteins in head and neck cancer cells in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at proteins in head and neck cancer cells.

Conditions

Interventions

GENETIC

Southern blotting

GENETIC

TdT-mediated dUTP nick end labeling assay

GENETIC

gene expression analysis

GENETIC

protein expression analysis

OTHER

flow cytometry

OTHER

fluorescent antibody technique

OTHER

immunoenzyme technique

OTHER

immunohistochemistry staining method

OTHER

immunologic technique

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Vanderbilt University Medical Center

    lead OTHER

Principal Investigators

  • Wendell G. Yarbrough, MD, FACS · Vanderbilt-Ingram Cancer Center

Eligibility

Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00896948 on ClinicalTrials.gov